Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))

Filiaciones

Rolfo C.:

Thoracic Oncology Department and Early Phase Clinical Trials Section, School of Medicine, Maryland University, Maryland, United States

Cardona A.F.:

Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia

Foundation for Clinical and Applied Cancer Research – FICMAC, Bogotá, Colombia

Universidad. Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia

Cristofanilli M.:

Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, 710 N Fairbanks Court, Suite 8-250A, Chicago, 60611, IL, United States

Paz-Ares L.:

Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Universidad Complutense and CIBERONC, Madrid, Spain

Diaz Mochon J.J.:

DestiNA Genomica S.L. Parque Tecnológico Ciencias de la Salud (PTS), Edificio BIC, Avenida de la Innovación 1, Armilla, Granada, 18016, Spain

GENYO Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada - Avenida de la Ilustración, Granada, 114- 18016, Spain

Department Medicinal and Organic Chemistry, School of Pharmacy, University of Granada, Campus Cartuja s/n, Granada, 18071, Spain

Duran I.:

Servicio de Oncologia Medica, Medical Oncology Department, Hospital Universitario Marques de Valdecilla, Edificio Sur, 2 Planta, Despacho 277, Santander, 39008, Spain

Raez L.E.:

Memorial Cancer Institute, Memorial Health Care System, Florida International University, Florida, United States

Russo A.:

Thoracic Oncology Department and Early Phase Clinical Trials Section, School of Medicine, Maryland University, Maryland, United States

Medical Oncology Unit A.O. Papardo & Department of Human Pathology, University of Messina, Italy

Lorente J.A.:

Laboratory of Genetic Identification, Department of Legal Medicine, University of Granada, Av. de la Investigación, 11, Granada, 18071, Spain

Centre for Genomics and Oncological Research - GENYO, Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain

Malapelle U.:

Department of Public Health, University Federico II of Naples, Naples, Italy

Gil-Bazo I.:

Department of Oncology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain

University of Navarra, Center for Applied Medical Research, Program of Solid Tumors, Pamplona, Navarra, Spain

Idisna, Navarra Institute for Health Research, Pamplona, Navarra, Spain

Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain

Jantus-Lewintre E.:

Molecular Oncology Laboratory, Fundación Investigación, Valencia General University Hospital, Valencia, Spain

Pauwels P.:

Center for Oncological Research (CORE), University of Antwerp, & Department of Pathology, Antwerp University Hospital, Edegem, Belgium

Mok T.:

State Key Laboratory in Oncology in South China, Hong Kong

Serrano M.J.:

Centre for Genomics and Oncological Research - GENYO, Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain

Bio-Health Research Institute (Instituto de Investigación Biosanitaria ibs. GRANADA), Spain

Complejo Hospitalario Universitario Granada (CHUG), Department of Medical Oncology, University of Granada, Granada, Spain